Market sentiment signals for Lineage Cell Therapeutics (LCTX): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
7 analysts
Options Flow (P/C)
—
Avg Consensus PT
$5
+454.5%
Highest Price Target
$9
+819.0%
Lowest Price Target
$3
+206.3%
Short Interest
19.1%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | HC Wainwright & Co. | Joseph Pantginis— | +819.0% | $9 → $9 | Maintained | Buy |
| May 4, 2026 | D. Boral Capital | Jason Kolbert— | +206.3% | $3 → $3 | Maintained | Buy |
